Smarter Clinical Trials
Begin Here

Optimize and implement Bayesian, adaptive, and fixed trial designs.
Analyze data to uncover heterogeneous treatment effects, stratify patients, and identify early endpoints for better trial planning.
Uncover biomarker correlations, refine treatment strategies, and guide indication selection with causal disease modeling.
Optimize site selection, obtain real-time trial and site performance analytics and integrate virtual control arms.

Reach Out

What platform application(s) are you most interested in learning about? *

Trial Optimizer

Causal-ML for HTE

Causal Disease Modeling

Clinical Operations

The Whole Platform

Other

Could you please share any context around the challenges or problems you’re hoping to address?

By submitting your details you hereby agree to our Privacy Policy. You may always opt-out from our mailing list in accordance with the Privacy Policy.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Frequently Asked Questions

What makes PhaseV unique?

Multi-Modal AI/ML Platform – PhaseV delivers a truly end-to-end solution that seamlessly bridges retrospective data analysis with trial design. Our platform optimizes adaptive, Bayesian, and fixed trial designs, identifies early-derived endpoints, and uncovers heterogeneous treatment effects—empowering sponsors to make data-driven decisions across the clinical development lifecycle. The platform’s Clinical Operations module also includes causal machine learning–driven site selection and real-time monitoring of trial and site performance analytics, among other applications.

Scientific & Regulatory Expertise – We are more than a technology company. PhaseV collaborates closely with leading scientific and regulatory experts to ensure our recommendations are rigorous, actionable, and regulatory-ready—helping sponsors navigate complex clinical landscapes with confidence.

Robust Data Infrastructure – PhaseV is powered by a high-quality data lake that includes granular patient-level data —covering biomarkers, clinical trial history, comorbidities, medications, and more—as well as curated real-world data (RWD) and scientific literature. Much of this is natively integrated into the platform, enabling immediate insights. Sponsors can also securely layer in their proprietary data, which remains isolated and fully protected.

Gen-AI Integration – Our platform enriches real-time data as it’s generated, enabling rapid construction and refinement of placebo priors, virtual control arms, and synthetic datasets. This accelerates trial execution and reduces reliance on traditional control groups.

Our AI/ML-powered, expert-driven approach ensures that PhaseV is not just a tool, but a strategic partner in clinical trial innovation.

How can we work with PhaseV?

Tech-Enabled Services – Sponsors/CROs can contract PhaseV on a per project basis to deliver its tech-enabled services. Prior to initiating a project, sponsors and PhaseV define the scope of work and align on timelines and cost. A dedicated team of ML, data-science, clinical and medical experts, tailored for each project offers white glove service and support throughout the duration of the project.

Software as a Service (SaaS) – Sponsors and CROs can purchase subscriptions to one or more PhaseV platform modules for self-serve use. Ongoing troubleshooting support and customization options are available, tailored to meet the specific needs of each sponsor and trial. PhaseV platform is cloud-native, hosted on Amazon Web Services (AWS), and compatible with most EDC systems.

What therapeutic areas does PhaseV cover?

PhaseV is therapeutic area agnostic. Our platform and expertise can be applied across a broad range of disease areas. We’ve demonstrated success in oncology, neurology, immunology, metabolic disorders, and rare diseases. Our capabilities support sponsors across the full continuum of clinical development, including data analysis, trial design, site selection, trial and site performance analytics, lifecycle management (such as indication selection and sequencing), asset evaluation, construction of virtual control arms, and more.

How does PhaseV ensure data security and privacy protection?

Data security is a top priority at PhaseV. We are ISO 27001 certified, GDPR, and HIPAA compliant, ensuring the highest standards of information security and privacy protection.

We have implemented strict policies and controls covering:

Data transfer, integrity, and handling
Limited access & authorizations
Audit trails & data deletion protocols
Risk management, ongoing monitoring, and audits

PhaseV adheres to all applicable laws, regulations, and industry standards to maintain the integrity and security of sensitive information.

Smarter Clinical TrialsBegin Here

Frequently Asked Questions

Smarter Clinical Trials
Begin Here